Mahoney Stephen F. 4/A

What Happened
Stephen F. Mahoney, President, CEO and Director of Viridian Therapeutics (VRDN), reported an amended Form 4 showing the disposition of 7,408 shares on 2026-03-03. The shares were disposed under transaction code F (payment of exercise price or tax liability) at $30.19 per share for proceeds of approximately $223,648. The filing amends an initial Form 4 filed March 4, 2026 to correct the number of shares and price sold and the resulting beneficial ownership.

Key Details

• Transaction date: 2026-03-03; Price: $30.19 per share
• Shares disposed: 7,408; Gross value ≈ $223,648
• Transaction code: F — payment of exercise price or tax liability (shares withheld/sold to cover taxes)
• Filing: Amended Form 4 filed 2026-03-09 (footnote F1 corrects the original March 4, 2026 Form 4)
• Shares owned after transaction: Not specified in the text provided here — see the amended Form 4 for the corrected total beneficial ownership

Context
Code F transactions are typically sell-to-cover or net-share-withholdings to satisfy taxes from a prior option exercise and are generally considered routine administrative transactions rather than open-market investment decisions. For a clearer view of insider intent, look for open-market buys or larger voluntary sales; amended filings like this correct reporting details and do not by themselves indicate a change in view.